Preview Mode Links will not work in preview mode

Innovate Fort Worth

Apr 25, 2023

More than 6 million Americans are living with Alzheimer’s Disease, and even more with Dementia and Parkinson’s. Cx Precision Medicine’s CEO, Danguole Altman, is focused on tackling this big problem for an aging population. Based on Dr. Sid O’Bryant’s revolutionary research at HSC, Cx Precision Medicine is bringing this important diagnostic technology to help people all over the world. Through a clinical diagnostic, Cx Precision Medicine is conducting screening tests to detect Alzheimer’s and other neurodegenerative diseases based on blood biomarkers, AI and machine learning. Cx aims to “Change eXpectations” around how doctors diagnose Alzheimer’s and dementia.

Want to learn more? Listen to episodes 20 and 21 with Dr. Sid O’Bryant to learn more about his research.

To learn more about Cx Precision Medicine, visit their website at

To learn more about HSC Next, visit